These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2545750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy.
    Sawai T, Ikai K, Uehara M.
    Br J Dermatol; 1998 May; 138(5):846-8. PubMed ID: 9666832
    [Abstract] [Full Text] [Related]

  • 8. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.
    Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR, Kirby DS, Weiner ES.
    J Invest Dermatol; 1996 Jul; 107(1):51-6. PubMed ID: 8752839
    [Abstract] [Full Text] [Related]

  • 9. Intracellular 3',5'-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis.
    Kanda N, Watanabe S.
    J Invest Dermatol; 2001 Jan; 116(1):3-11. PubMed ID: 11168792
    [Abstract] [Full Text] [Related]

  • 10. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
    Grewe SR, Chan SC, Hanifin JM.
    J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
    [Abstract] [Full Text] [Related]

  • 11. The effect of in vitro exposure to histamine on mononuclear leucocyte phosphodiesterase activity in atopic dermatitis.
    Holden CA, Yuen CT, Coulson IH.
    Clin Exp Dermatol; 1989 May; 14(3):186-90. PubMed ID: 2556225
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents.
    Heskel NS, Chan SC, Thiel ML, Stevens SR, Casperson LS, Hanifin JM.
    J Am Acad Dermatol; 1984 Sep; 11(3):422-6. PubMed ID: 6090514
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis.
    Jarnagin K, Chanda S, Coronado D, Ciaravino V, Zane LT, Guttman-Yassky E, Lebwohl MG.
    J Drugs Dermatol; 2016 Apr; 15(4):390-6. PubMed ID: 27050693
    [Abstract] [Full Text] [Related]

  • 17. Dohi Memorial Lecture. New therapeutic rewards from clinical research in atopic dermatitis.
    Hanifin JM.
    J Dermatol; 1994 Oct; 21(10):705-8. PubMed ID: 7798424
    [No Abstract] [Full Text] [Related]

  • 18. Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis.
    Rupprecht M, Rupprecht R, Kornhuber J, Wodarz N, Koch HU, Riederer P, Hornstein OP.
    Dermatologica; 1991 Oct; 183(2):100-5. PubMed ID: 1660414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.